ADVFN US – Market Content Editor
-

Wall Street Futures Decline as Nvidia Leadership Uncertainty and Inflation Concerns Weigh on Markets: Dow Jones, S&P, Nasdaq
US stock index futures pointed to a lower opening on Monday, extending the cautious market sentiment seen during the previous two trading sessions, as investors assessed uncertainty surrounding Nvidia’s leadership, inflation developments and the outlook for Federal Reserve interest rates. Technology stocks remained under pressure, with Nvidia (NASDAQ:NVDA) falling approximately 3.3% in premarket trading ahead…
-

Tyson Foods Beats Q4 Earnings and Revenue Estimates, Forecasts Lower Sales in Fiscal 2027
Tyson Foods Inc. (NYSE:TSN) reported fourth-quarter adjusted earnings of $0.61 per share, exceeding analyst expectations of $0.60, while revenue of $14.59 billion was above the consensus forecast of $14.1 billion. Shares in the US food producer rose 1.2% in premarket trading on Monday following the earnings announcement. The company reported a decline in quarterly adjusted…
-

Nvidia Shares Fall 3.5% Premarket as Leadership Uncertainty Overshadows Upcoming Earnings
Nvidia (NASDAQ:NVDA) shares declined approximately 3.5% in premarket trading on Monday, extending losses from the previous week as investors assessed the implications of Jensen Huang’s reported removal as chief executive ahead of the semiconductor company’s fiscal third-quarter earnings announcement. The stock closed at $162.85 on Friday, leaving Nvidia’s market capitalisation below $4 trillion following a…
-

L3Harris Shares Fall 4% After US Transportation Secretary Links Contractor to Nationwide Aviation Disruption
L3Harris Technologies (NYSE:LHX) shares declined 4% in premarket trading on Monday after US Transportation Secretary Sean Duffy raised concerns about the defence contractor’s work on air traffic control infrastructure following a nationwide aviation system disruption on Friday. The incident resulted in a ground stop lasting nearly five hours and affected more than 20,000 flights across…
-

Eli Lilly to Acquire Calytrix Bio for Up to $1.5 Billion to Expand Blood Cancer Portfolio
Eli Lilly and Company (NYSE:LLY) has agreed to acquire privately held biotechnology company Calytrix Bio in a cash transaction valued at up to $1.5 billion, expanding its development portfolio of treatments for rare blood cancers. The agreement, announced by Calytrix on Monday, includes an initial cash payment and additional consideration linked to the achievement of…
-

Nvidia CEO Jensen Huang Return Seen as Unlikely by Lynx Equity Strategies Analyst
The possibility of Jensen Huang returning to Nvidia (NASDAQ:NVDA) has prompted renewed discussion about the semiconductor company’s leadership following reports that prominent Silicon Valley executives are seeking to support his reinstatement. However, Lynx Equity Strategies believes a return is highly unlikely, citing the circumstances surrounding his departure and the challenges facing Nvidia’s board. In a…
-

Lexeo Therapeutics Reports LX2020 Gene Therapy Trial Data and Outlines Potential FDA Accelerated Approval Pathway
Lexeo Therapeutics (NASDAQ:LXEO) has reported interim Phase I/II clinical trial results for LX2020, its investigational gene therapy for PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM), alongside an update on discussions with the US Food and Drug Administration regarding a potential accelerated approval pathway. The company said participants receiving higher doses of LX2020 demonstrated a mean reduction of 80%…
-

Hyperscale Data Reports Preliminary Q3 Revenue Growth of 84% to $44.8 Million
Hyperscale Data, Inc. (AMEX:GPUS) has reported preliminary unaudited revenue of approximately $44.8 million for the third quarter ended September 30, 2026, representing an increase of around 84% from the $24.3 million recorded in the corresponding period last year. The reported figure also exceeded the company’s previous internal revenue estimate of approximately $40 million by 12%.…
-

XPeng Shares Gain Over 3% as Third-Quarter Revenue Beats Forecasts and Q4 Delivery Outlook Exceeds Expectations
XPeng Inc. (NYSE:XPEV) shares advanced more than 3% in premarket trading on Monday after the Chinese electric vehicle manufacturer reported third-quarter revenue above analyst expectations and forecast a substantial increase in vehicle deliveries during the final quarter of 2026. Revenue for the third quarter rose 19.1% year on year to 24.28 billion yuan ($3.62 billion),…
-

Cerenome Reports Interim REYOBIQ Repeat-Dosing Data in Leptomeningeal Metastases Study
Cerenome, Inc. (NASDAQ:CNSY) has presented interim clinical data from its ongoing ReSPECT-LM study evaluating repeated intraventricular administration of REYOBIQ (rhenium Re186 obisbemeda) in patients with leptomeningeal metastases, a form of cancer involving the membranes surrounding the brain and spinal cord. The findings, covering the first 10 patients treated in the study, were presented at the…